[go: up one dir, main page]

FI84064C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla silibininderivat. - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla silibininderivat. Download PDF

Info

Publication number
FI84064C
FI84064C FI854535A FI854535A FI84064C FI 84064 C FI84064 C FI 84064C FI 854535 A FI854535 A FI 854535A FI 854535 A FI854535 A FI 854535A FI 84064 C FI84064 C FI 84064C
Authority
FI
Finland
Prior art keywords
silibinin
ethanol
ethyl acetate
animals
parts
Prior art date
Application number
FI854535A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI854535A0 (fi
FI84064B (fi
FI854535A (fi
Inventor
Reinhard Braatz
Klaus Goerler
Guenter Halbach
Hartwig Soicke
Karlheinz Schmidt
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of FI854535A0 publication Critical patent/FI854535A0/fi
Publication of FI854535A publication Critical patent/FI854535A/fi
Application granted granted Critical
Publication of FI84064B publication Critical patent/FI84064B/fi
Publication of FI84064C publication Critical patent/FI84064C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
FI854535A 1984-11-22 1985-11-18 Foerfarande foer framstaellning av farmakologiskt vaerdefulla silibininderivat. FI84064C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten
DE3442639 1984-11-22

Publications (4)

Publication Number Publication Date
FI854535A0 FI854535A0 (fi) 1985-11-18
FI854535A FI854535A (fi) 1986-05-23
FI84064B FI84064B (fi) 1991-06-28
FI84064C true FI84064C (fi) 1991-10-10

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854535A FI84064C (fi) 1984-11-22 1985-11-18 Foerfarande foer framstaellning av farmakologiskt vaerdefulla silibininderivat.

Country Status (29)

Country Link
JP (1) JPS61143377A (da)
KR (1) KR870001020B1 (da)
AR (1) AR240931A1 (da)
AT (1) AT393268B (da)
BE (1) BE903693A (da)
CA (1) CA1337124C (da)
CH (1) CH659473A5 (da)
CS (1) CS273610B2 (da)
DD (1) DD259191A1 (da)
DE (1) DE3442639A1 (da)
DK (1) DK164865C (da)
EG (1) EG19424A (da)
ES (1) ES8609311A1 (da)
FI (1) FI84064C (da)
FR (1) FR2573427B1 (da)
GB (1) GB2167414B (da)
HU (1) HU195503B (da)
IE (1) IE58791B1 (da)
IT (1) IT1190426B (da)
LU (1) LU86163A1 (da)
MX (1) MX168415B (da)
NL (1) NL192387C (da)
NO (1) NO160205C (da)
PL (1) PL146890B1 (da)
PT (1) PT81532B (da)
SE (1) SE465676B (da)
SU (1) SU1436875A3 (da)
YU (1) YU43689B (da)
ZA (1) ZA858951B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
DK1856085T3 (da) * 2005-03-11 2015-10-05 Howard Florey Inst Pty Ltd Flavonoidforbindelser og anvendelser deraf
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
WO2009062737A1 (en) * 2007-11-15 2009-05-22 Madaus Gmbh Silibinin component for the treatment of hepatitis
AU2010247716B2 (en) * 2009-05-14 2015-11-05 Madaus Gmbh Amorphous silibinin for the treatment of viral hepatitis
US20150174213A1 (en) 2012-07-05 2015-06-25 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
GB8528226D0 (en) 1985-12-18
JPS61143377A (ja) 1986-07-01
FI854535A0 (fi) 1985-11-18
FR2573427A1 (fr) 1986-05-23
ES549116A0 (es) 1986-09-01
HU195503B (en) 1988-05-30
BE903693A (fr) 1986-05-22
YU43689B (en) 1989-10-31
NO160205B (no) 1988-12-12
SE8505487D0 (sv) 1985-11-20
CA1337124C (en) 1995-09-26
DK164865C (da) 1993-01-18
CS837885A2 (en) 1990-08-14
DE3442639C2 (da) 1989-08-10
AR240931A1 (es) 1991-03-27
FR2573427B1 (fr) 1989-03-10
HUT40114A (en) 1986-11-28
YU178685A (en) 1988-02-29
DK164865B (da) 1992-08-31
FI84064B (fi) 1991-06-28
ES8609311A1 (es) 1986-09-01
AR240931A2 (es) 1991-03-27
LU86163A1 (de) 1986-03-24
GB2167414A (en) 1986-05-29
EG19424A (en) 1995-02-28
DE3442639A1 (de) 1986-05-22
DK537785D0 (da) 1985-11-21
JPH0432073B2 (da) 1992-05-28
IT1190426B (it) 1988-02-16
SU1436875A3 (ru) 1988-11-07
NL8503171A (nl) 1986-06-16
KR860004056A (ko) 1986-06-16
ZA858951B (en) 1986-08-27
DK537785A (da) 1986-05-23
NL192387B (nl) 1997-03-03
PT81532A (de) 1985-12-01
CS273610B2 (en) 1991-03-12
CH659473A5 (de) 1987-01-30
SE8505487L (sv) 1986-05-23
AT393268B (de) 1991-09-25
KR870001020B1 (ko) 1987-05-23
PT81532B (pt) 1987-11-11
ATA337185A (de) 1991-02-15
IE58791B1 (en) 1993-11-17
NO854655L (no) 1986-05-23
IT8522932A0 (it) 1985-11-21
NL192387C (nl) 1997-07-04
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
MX168415B (es) 1993-05-24
DD259191A1 (de) 1988-08-17
PL256374A1 (en) 1986-12-02
GB2167414B (en) 1989-01-11
FI854535A (fi) 1986-05-23
NO160205C (no) 1989-03-22
IE852808L (en) 1986-05-22

Similar Documents

Publication Publication Date Title
US4764508A (en) Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions
EP0275224B1 (fr) Complexes phospholipidiques d'extraits de Vitis vinifera, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
EP1516866B1 (en) Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
FI84064C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla silibininderivat.
US3988446A (en) Glycerides with anti-inflammatory properties
FI84065B (fi) Foerfarande foer framstaellning av isosilybinfri silibinin.
JPH06145174A (ja) ビロバリデ誘導体,この用途及びこれを含有する薬剤 組成物
SK194892A3 (en) Method of production of diacetylreine
US8092845B2 (en) Anti-inflammatory extract and agent and method for the production thereof
KR20010052637A (ko) 하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제
GB2261434A (en) New radical scavenging and antipoperoxidant flavanolignans their preparation and formulations for therapeutic use
SI8511786A8 (sl) Postopek za pripravo derivatov silibinina
JP2005523301A (ja) Barleriaprionitislinnからの抽出物を含む製薬組成物、およびその調製方法
WO1981003489A1 (en) Process for separating medicinal ingredient from corbicula by extraction and composition containing same
CH665642A5 (fr) Derives de l'aminomethyle-6 furo-(3,4-c)-pyridine, leur preparation et compositions therapeutiques en contenant.
JP4465432B2 (ja) 新規なジテルペン化合物
Yusupova et al. New Source Of Synthesis Of Physiologically Active Substonces
FR2650999A1 (fr) Chlorhydrate de 1-(2-ethoxyethyl)-4-phenyl-4-propionyloxypiperidine
BE877014A (fr) Nouveaux derives phospholipidiques a activite anti-lipemique et anti-arteriosclerotique.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MADAUS AKTIENGESELLSCHAFT